A blood based biomarker identifying early Alzheimer Disease's pathology

Informazioni relative al progetto

VERDAD

ID dell’accordo di sovvenzione: 849834

DOI 10.3030/849834

Progetto chiuso

Data della firma CE 24 Maggio 2019

Data di avvio 1 Giugno 2019

Data di completamento 30 Novembre 2021

Finanziato da

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Costo totale € 3 365 416,25

Contributo UE € 2 355 791,00

Coordinato da

PRE DIAGNOSTICS AS
Norway

Risultati finali

Demonstrators, pilots, prototypes (1)

Direct monocyte lysis and Aβ peptides recovery protocol

Websites, patent fillings, videos etc. (3)

Project website
Final project report

Final project report1PreDDECPUM30

Fully characterized mid domain beta Amyloid peptide mapping

Documents, reports (6)

Final protocol for large scale deployment of a fully automated method for Aβ peptides recovery from blood monocytes
Ethical approvals for the planned testing activities
Performance report from the in-vitro reference solutions tests
Societal demo activities report
CE-label documentation

CElabel documentation

Final automated immunoassay protocol

Open Research Data Pilot (1)

Performance report from the clinical blood samples

Diritti di proprietà intellettuale

Patent (2)

METHODS AND COMPOSITIONS FOR MONITORING PHAGOCYTIC ACTIVITY

Numero candidatura/pubblicazione: 11 805939
Data: 2011-11-28

DIAGNOSTIC METHOD

Numero candidatura/pubblicazione: 09 709860
Data: 2009-02-13